<SEC-DOCUMENT>0001104659-24-073992-index.html : 20240621 <SEC-HEADER>0001104659-24-073992.hdr.sgml : 20240621 <ACCEPTANCE-DATETIME>20240621171556 ACCESSION NUMBER: 0001104659-24-073992 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20240621 DATE AS OF CHANGE: 20240621 EFFECTIVENESS DATE: 20240621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Annovis Bio, Inc. CENTRAL INDEX KEY: 0001477845 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 262540421 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-280417 FILM NUMBER: 241061385 BUSINESS ADDRESS: STREET 1: 101 LINDENWOOD DRIVE, SUITE 225 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 484-875-3192 MAIL ADDRESS: STREET 1: 101 LINDENWOOD DRIVE, SUITE 225 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: QR Pharma, Inc. DATE OF NAME CHANGE: 20091202 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>tm2417417d1_s8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: tm2417417d1_s8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>tm2417417d1_ex5-1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: tm2417417d1_ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>tm2417417d1_ex23-1.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 3 - file: tm2417417d1_ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>4 <FILENAME>tm2417417d1_ex23-2.htm <DESCRIPTION>EXHIBIT 23.2 <TEXT> Document 4 - file: tm2417417d1_ex23-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>5 <FILENAME>tm2417417d1_ex-filingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 5 - file: tm2417417d1_ex-filingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>tm2417417d1_ex5-1img001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: tm2417417d1_ex5-1img001.jpg
</DOCUMENT> </SEC-DOCUMENT>